2Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med, 2005, 257: 374-384. 被引量：1
3Rehman Q, Lane NE. Effect of glucocorticoids on bone density. Med Pediatr Oncol, 2003, 41: 212-216. 被引量：1
4Clowes JA, Peel N, Eastell R, et al. Glucocorticoid-induced osteoporosis. Curr Opin Rheumatol, 2001, 13: 326-332. 被引量：1
5Westhovens R, Dequeker J. Rheumatoid arthritis and osteoporosis. Z Rheumatol, 2000, 59 Suppl 1: 33-38. 被引量：1
6Di Munno O, Mazzantini M, Delle-Scdle A, et al. Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus, 2004, 13: 724-730. 被引量：1
7Gilboe IM, Kvien TK, Haugeberg G, et al. Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls. Ann Rheum Dis, 2000, 59: 110- 115. 被引量：1
8Almehed K, Forsblad d'Ella H, Kvist G, et al. Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatology (Oxford), 2007, 46:1185-1190. 被引量：1
9Bodolay E, Bettembuk P, Balogh A, et al. Osteoporosis in mixed connective tissue disease. Clin Rheumatol, 2003, 22: 213-217. 被引量：1
10Li EK, Tam LS, Young RP, et al. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol, 1998, 37: 405- 410. 被引量：1
